Maravai LifeSciences Holdings Inc [MRVI] stock is trading at $5.95, up 4.75%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The MRVI shares have gain 8.18% over the last week, with a monthly amount glided 9.88%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Goldman downgraded its rating to Sell on December 05, 2024, and kept the price target unchanged to $4.25. On November 14, 2024, Wolfe Research initiated with a Peer Perform rating. William Blair downgraded its rating to a Mkt Perform. Wells Fargo initiated its recommendation with a Overweight and recommended $10 as its price target on August 28, 2024. Morgan Stanley downgraded its rating to Equal-Weight for this stock on August 13, 2024, and downed its price target to $10. In a note dated April 10, 2024, Craig Hallum initiated an Buy rating and provided a target price of $15 on this stock.
Maravai LifeSciences Holdings Inc [MRVI] stock has fluctuated between $4.28 and $11.56 over the past year. Currently, Wall Street analysts expect the stock to reach $19 within the next 12 months. Maravai LifeSciences Holdings Inc [NASDAQ: MRVI] shares were valued at $5.95 at the most recent close of the market. An investor can expect a potential return of 219.33% based on the average MRVI price forecast.
Analyzing the MRVI fundamentals
Maravai LifeSciences Holdings Inc [NASDAQ:MRVI] reported sales of 276.92M for the trailing twelve months, which represents a drop of -2.49%. Gross Profit Margin for this corporation currently stands at 0.44% with Operating Profit Margin at -0.71%, Pretax Profit Margin comes in at 1.59%, and Net Profit Margin reading is -0.81%. To continue investigating profitability, this company’s Return on Assets is posted at -0.18, Equity is -0.56 and Total Capital is -0.16. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.51.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 5.73 points at the first support level, and at 5.50 for the second support level. However, for the 1st resistance point, the stock is sitting at 6.09, and for the 2nd resistance point, it is at 6.22.
Ratios To Look Out For
For context, Maravai LifeSciences Holdings Inc’s Current Ratio is 10.74. Further, the Quick Ratio stands at 9.94, while the Cash Ratio is 9.14. Considering the valuation of this stock, the price to sales ratio is 5.61, the price to book ratio is 2.44.
Transactions by insiders
Recent insider trading involved DeFord John A, Director, that happened on Nov 12 ’24 when 17500.0 shares were purchased. HULL CARL completed a deal on Nov 11 ’24 to buy 0.17 million shares. Meanwhile, Director GTCR INVESTMENT XI LLC sold 9.94 million shares on May 28 ’24.
